Sunrise Medical

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022-2023🗂️ Report periods on file: 2022-2023

In its 2022-2023 reporting, Sunrise Medical disclosed greenhouse gas emissions of 44.1K tCO2e (2023). By scope: Scope 1: 8.2K tCO2e (2023); Scope 2: 3.4K tCO2e (2023); Scope 3: 32.5K tCO2e (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
44.1K tCO2e (2023)
2022-2023

📊 Emissions by Scope (2022-2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).8.2K tCO2e (2023)
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.3.4K tCO2e (2023)
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).32.5K tCO2e (2023)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • 75% recycled waste by 2030
  • 80% recyclable outbound packaging by 2030
  • 75% hybrid/electric company-owned vehicles by 2030
  • 40% women in the workplace by 2030
  • 30% women in management by 2030

🔭 Long-term

  • Reduce absolute GHG emissions (Scopes 1 & 2) to net zero by 2050

🌱 ESG Focus Areas

Innovation in our Products & ServicesReducing our Environmental FootprintCommitment to Customer Satisfaction & ServiceCommitment to Our EmployeesResponsible Procurement & LogisticsEthical & Sustainable Business Practices

⚠️ Challenges & Risks +

  • Increasing Scope 1 GHG emissions from 2021 to 2023
  • Increase in Scope 3 GHG emissions during the same timeframe
  • Customer satisfaction rate varies by country

📋 Report Information

Reporting Period: 2022-2023
Frameworks: GRI Standards